HealthManagement, Volume 1 - Issue 1, November-December 2007
The goal of the trial is to increase understanding of how heart disease affects women and to assess the performance of the Xience™ V Everolimus Eluting Coronary Stent System in women with previously untreated coronary artery lesions from Europe, Asia-Pacific, Canada and Latin America. The trial will focus on specific aspects of women’s health in relation to coronary artery disease such as general awareness about the disease, symptoms at time of presentation, referral patterns, and hormonal menopausal status.